Psychedelic Integration Reading List

Foundational Books for Understanding Psychedelics

How to Change Your Mind by Michael Pollan (Penguin Press, 2018) is arguably the most important popular introduction to psychedelics published in the past two decades. Pollan, a science journalist without prior psychedelic experience, investigates the history of LSD and psilocybin research, undergoes his own guided sessions, and synthesizes neuroscience with a deep examination of consciousness. The book is credited with significantly shifting mainstream attitudes toward psychedelic therapy and is frequently recommended as the starting point for newcomers.

The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead by Timothy Leary, Ralph Metzner, and Richard Alpert (1964) is the foundational text of the modern Western psychedelic movement. Drawing on the Bardo Thodol, it frames the psychedelic journey as analogous to stages of death and rebirth described in Tibetan Buddhist cosmology. While its 1960s cultural context is dated, it remains a cornerstone of psychedelic literature and introduces concepts like set and setting that are still central to contemporary therapeutic practice.

Stealing Fire: How Silicon Valley, the Navy SEALs, and Maverick Scientists Are Revolutionizing the Way We Live and Work by Steven Kotler and Jamie Wheal (2017) examines non-ordinary states of consciousness — including those produced by psychedelics — from the perspective of performance psychology and flow states. It provides valuable context for understanding why altered states are being explored across elite military, athletic, and technological contexts, and connects psychedelic experiences to broader frameworks of self-optimization and collective intelligence.

Your Psilocybin Mushroom Companion by Michelle Janikian (Ulysses Press, 2019) is a practical, harm-reduction-focused guide that covers preparation, ceremony design, dosing, difficult experiences, and integration. Written for people who may use psilocybin in non-clinical settings, it fills an important gap between purely theoretical or clinical texts and real-world use. Janikian provides detailed checklists, integration journaling prompts, and advice on supporting others through their experiences.

Historical and Scholarly Texts

The Road to Eleusis: Unveiling the Secret of the Mysteries by R. Gordon Wasson, Albert Hofmann, and Carl A.P. Ruck (1978) makes the provocative scholarly argument that the kykeon — the sacred drink consumed at the ancient Greek Eleusinian Mysteries — was an ergot-derived psychedelic preparation. The three authors bring expertise in ethnobotany, chemistry, and classical Greek scholarship to argue that psychedelic-assisted mystical experience formed the core of the most important religious institution of ancient Greece for nearly 2,000 years. Though contested by some classicists, it remains a landmark interdisciplinary work.

Psychedelic Medicine: The Healing Powers of LSD, MDMA, Psilocybin, and Other Psychedelic Drugs by Dr. Richard Louis Miller (Park Street Press, 2017) presents a series of interviews with leading researchers including Rick Doblin (MAPS), Charles Grob, and others working at the intersection of psychopharmacology and psychotherapy. It provides an accessible survey of clinical applications across depression, PTSD, addiction, and end-of-life anxiety without requiring a scientific background.

Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers by Richard Evans Schultes and Albert Hofmann (1979) documents ethnobotanical use of psychoactive plants across indigenous cultures worldwide. Schultes' decades of fieldwork in the Amazon and Hofmann's chemistry expertise combine to produce an unmatched cross-cultural survey. For those interested in the deep history of psilocybin-containing mushrooms in Mazatec and other Mesoamerican traditions, this is essential reading.

Academic Research Papers and Clinical Literature

The most important peer-reviewed research in the field comes primarily from three institutions: the Multidisciplinary Association for Psychedelic Studies (MAPS), the Johns Hopkins Center for Psychedelic and Consciousness Research, and the Imperial College London Centre for Psychedelic Research. Key papers accessible through PubMed include:

Davis, A.K. et al. (2021). "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder." JAMA Psychiatry — the landmark Johns Hopkins randomized controlled trial showing rapid and durable antidepressant effects of two psilocybin sessions combined with supportive therapy, with 71% of participants showing a significant response at four weeks.

Carhart-Harris, R. et al. (2021). "Trial of Psilocybin versus Escitalopram for Depression." New England Journal of Medicine — the Imperial College London head-to-head comparison of psilocybin against the SSRI escitalopram (Lexapro) in treatment-resistant depression, showing comparable efficacy with a faster onset and qualitatively different emotional impact. MAPS publishes research updates and full papers through their website at maps.org, and the Johns Hopkins research team maintains a publication archive at hopkinspsychedelic.org.

For integration specifically, look for work by Françoise Bourzat, Friederike Meckel Fischer, and Bill Richards on the phenomenology of psilocybin experiences and therapeutic frameworks for processing their content.

Building a Personal Integration Library

Effective integration reading is not about consuming as much information as possible but about returning repeatedly to texts that help you process your own experience. Journaling alongside reading — noting what resonates, what challenges your existing beliefs, and what questions arise — substantially deepens the benefit of any integration reading practice.

A practical starting sequence for someone new to psychedelics and integration literature: begin with Pollan's How to Change Your Mind for cultural and historical context, then Janikian's Psilocybin Mushroom Companion for practical preparation and integration frameworks, then the Davis et al. JAMA Psychiatry paper to understand what the clinical research actually shows. From there, follow your interests — whether into history (Wasson), neuroscience (Robin Carhart-Harris's work), philosophy of mind, or therapeutic practice (Bill Richards' Sacred Knowledge, 2015).

Frequently Asked Questions

What book should I read first to learn about psychedelic integration?

Most people find Michael Pollan's How to Change Your Mind the most accessible and well-rounded starting point, covering history, neuroscience, and personal experience. For practical integration guidance specifically, Michelle Janikian's Your Psilocybin Mushroom Companion provides actionable frameworks and journaling prompts suited to people working outside clinical settings.

What is "integration" in the context of psychedelics?

Integration refers to the process of making meaning from psychedelic experiences and translating insights or emotional shifts into lasting changes in behaviour, perspective, and wellbeing. It encompasses reflection, journaling, conversation with trusted others, somatic practices, and sometimes working with a therapist to process challenging content that emerged during a session.

Where can I find the original clinical research papers on psilocybin?

Most major studies are freely available through PubMed (pubmed.ncbi.nlm.nih.gov), where you can search for "psilocybin" combined with terms like "depression," "anxiety," or "addiction." The Johns Hopkins Center for Psychedelic and Consciousness Research (hopkinspsychedelic.org) and MAPS (maps.org) both maintain publication archives with links to full papers.

Is The Psychedelic Experience by Leary still relevant?

Yes, though it should be read as a historical and philosophical text rather than a literal guide. Its core insight — that the mindset and framing brought to a psychedelic experience shapes its content and outcome — remains foundational to contemporary therapeutic practice. The concept of set and setting that Leary helped popularize is now empirically supported by clinical research.

What does the research from Johns Hopkins show about psilocybin?

The 2021 Davis et al. trial published in JAMA Psychiatry found that two psilocybin sessions combined with supportive therapy produced rapid, significant reductions in depression symptoms, with 71% of participants showing a clinically meaningful response and 54% achieving remission at four weeks. Effects were maintained at a three-month follow-up, supporting the hypothesis that psilocybin can produce durable therapeutic change.

What is MAPS and why is their research important?

MAPS (Multidisciplinary Association for Psychedelic Studies) is a non-profit research organization founded by Rick Doblin in 1986 that has sponsored the most extensive clinical trials of MDMA-assisted therapy for PTSD, as well as psilocybin and other psychedelic research. Their Phase 3 MDMA-PTSD trial produced the data supporting FDA Breakthrough Therapy designation, and their published protocols and training materials are foundational documents for the emerging field of psychedelic-assisted therapy.

What is the Eleusis book about?

The Road to Eleusis by Wasson, Hofmann, and Ruck argues that the kykeon — the ritual drink consumed at the Eleusinian Mysteries, ancient Greece's most important religious institution — contained ergot-derived psychedelic alkaloids. The authors bring ethnomycology, organic chemistry, and classical scholarship together to suggest that psychedelic experience lay at the heart of Western civilization's most influential mystery cult for nearly two millennia.

How do I use reading as part of an integration practice?

The most effective approach combines reading with reflective journaling: after each reading session, write down what resonated, what created resistance, and what questions arose. Returning to the same passages weeks after an experience often reveals new meaning as your perspective continues to shift. Reading groups or discussion with trusted friends who share your interest can also deepen integration by externalizing and testing your interpretations.

Are there any books specifically about psilocybin and end-of-life anxiety?

The work of Bill Richards at Johns Hopkins, collected in Sacred Knowledge: Psychedelics and Religious Experiences (2015), addresses the intersection of psilocybin experiences and mortality extensively. The clinical research by Charles Grob on psilocybin for cancer-related distress, and the work by Tony Bossis at NYU, are also important — multiple papers from these researchers are freely available on PubMed.

What is the Imperial College London Centre for Psychedelic Research known for?

The Imperial College London Centre, led by Robin Carhart-Harris (now at UCSF), is best known for neuroimaging research that has mapped how psilocybin affects brain connectivity — including the finding that psilocybin disrupts the default mode network, a brain system associated with self-referential thought. Their 2021 NEJM trial comparing psilocybin to escitalopram for depression was a landmark study, and their REBUS (Relaxed Beliefs Under Psychedelics) model offers an influential theoretical framework for how psychedelics produce therapeutic effects.